ZIMP
TMO icon

Zimmermann Investment Management & Planning’s Thermo Fisher Scientific TMO Stock Holding History

Zimmermann Investment Management & Planning’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-493
Closed -$305K – 121
2024
Q3 		$305K Buy
493
+36
+8% +$21.3K 0.09% 112
2024
Q2 		$253K Sell
457
-117
-20% -$67K 0.08% 115
2024
Q1 		$334K Sell
574
-203
-26% -$114K 0.12% 103
2023
Q4 		$412K Sell
777
-132
-15% -$63.9K 0.17% 77
2023
Q3 		$460K Sell
909
-78
-8% -$41.6K 0.22% 70
2023
Q2 		$515K Buy
987
+47
+5% +$25.4K 0.24% 66
2023
Q1 		$542K Sell
940
-4
-0.4% -$2.25K 0.28% 64
2022
Q4 		$520K Sell
944
-10
-1% -$5.3K 0.3% 55
2022
Q3 		$484K Sell
954
-369
-28% -$207K 0.3% 53
2022
Q2 		$719K Sell
1,323
-18
-1% -$9.91K 0.49% 48
2022
Q1 		$792K Sell
1,341
-41
-3% -$23.6K 0.47% 47
2021
Q4 		$922K Buy
+1,382
New +$863K 0.52% 37

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Zimmermann Investment Management & Planning's TMO Position: Q4 2024 in Review

Zimmermann Investment Management & Planning sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 493 shares — an estimated $305K sold.

Zimmermann Investment Management & Planning first reported a position in TMO in Q4 2021 and held it in 12 quarters. The position peaked at $922K in Q4 2021. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Zimmermann Investment Management & Planning reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Zimmermann Investment Management & Planning sold 493 Thermo Fisher Scientific shares in Q4 2024, an estimated $305K.
  • Zimmermann Investment Management & Planning first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 12 quarters.
  • Zimmermann Investment Management & Planning's Thermo Fisher Scientific position peaked at $922K in Q4 2021.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Zimmermann Investment Management & Planning's 13F filing for Q4 2024, filed 23 Jan 2025.